BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9718021)

  • 1. Hereditary breast cancer.
    Hill A; McDermott E; O'Higgins N
    Br J Surg; 1998 Aug; 85(8):1157. PubMed ID: 9718021
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary breast cancer.
    Robson ME; Boyd J; Borgen PI; Cody HS
    Curr Probl Surg; 2001 Jun; 38(6):387-480. PubMed ID: 11375625
    [No Abstract]   [Full Text] [Related]  

  • 3. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
    Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC).
    Shen D; Vadgama JV
    Oncol Res; 1999; 11(2):63-9. PubMed ID: 10489161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.
    Vaziri SA; Krumroy LM; Rostai M; Casey G
    Hum Mutat; 2001; 17(1):74. PubMed ID: 11139249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary breast cancer.
    Gronwald J; Menkiszak J; Tołoczko A; Zajaczek S; Kładny J; Kurzawski G; Krzystolik K; Podolski J; Lubiński J
    Pol J Pathol; 1998; 49(2):59-66. PubMed ID: 9798408
    [No Abstract]   [Full Text] [Related]  

  • 8. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
    Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Generic screening for breast cancer].
    Ponti A; Giordano L
    Epidemiol Prev; 1999; 23(4):369-71. PubMed ID: 10730478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.
    Díez O; Osorio A; Robledo M; Barroso A; Domènech M; Cortés J; Albertos J; Sanz J; Brunet J; SanRomán JM; Alonso MC; Baiget M; Benítez J
    Br J Cancer; 1999 Mar; 79(7-8):1302-3. PubMed ID: 10098775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers.
    Phillips KA
    J Clin Oncol; 2000 Nov; 18(21 Suppl):107S-12S. PubMed ID: 11060337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary breast cancer.
    Hicken GJ; Francis A; Harries SA
    Br J Surg; 1998 Apr; 85(4):570-1. PubMed ID: 9607548
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.
    Gershoni-Baruch R; Dagan E; Fried G; Kepten I; Robinson E
    Eur J Hum Genet; 1999; 7(7):833-6. PubMed ID: 10573018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex decision-making for BRCA1/2 carriers.
    Matloff ET
    Cancer J Sci Am; 1999; 5(5):266-8. PubMed ID: 10526666
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroid hormones and genetic susceptibility to breast and prostate cancer.
    Feigelson HS; Ross RK; Yu MC; Coetzee GA; Reichardt JK; Henderson BE
    Drug Metab Rev; 1998 May; 30(2):421-34. PubMed ID: 9606611
    [No Abstract]   [Full Text] [Related]  

  • 19. BRCA: the breast, ovarian, and other cancer genes.
    Boyd J
    Gynecol Oncol; 2001 Mar; 80(3):337-40. PubMed ID: 11263927
    [No Abstract]   [Full Text] [Related]  

  • 20. Hereditary breast cancer: a review.
    Arver B; Du Q; Chen J; Luo L; Lindblom A
    Semin Cancer Biol; 2000 Aug; 10(4):271-88. PubMed ID: 10966850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.